Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 14 most recent Form 4 transactions.
| Jun 25 | TARS | Tarsus Pharmaceuticals,… | AGRANT◆ | 3,837 | — | — | — | Open the original filing on SEC.gov |
| Jun 1 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷◆ | 3,830 | — | — | — | Open the original filing on SEC.gov |
| Jun 1 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 17 | $302.65 | $5.1K | -1.1% | Open the original filing on SEC.gov |
| Jun 1 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 495 | $300.72 | $148.9K | -23.6% | Open the original filing on SEC.gov |
| Jun 1 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 1,222 | $299.87 | $366.4K | -36.9% | Open the original filing on SEC.gov |
| Jun 1 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 1,175 | $298.91 | $351.2K | -26.2% | Open the original filing on SEC.gov |
| Jun 1 | ALNY | Alnylam Pharmaceuticals,… | SSELL◷ | 921 | $297.71 | $274.2K | -17.0% | Open the original filing on SEC.gov |
| Jun 1 | ALNY | Alnylam Pharmaceuticals,… | MEXER◷ | 3,830 | — | — | +242.1% | Open the original filing on SEC.gov |
| May 20 | ALNY | Alnylam Pharmaceuticals,… | AGRANT◆ | 1,441 | — | — | — | Open the original filing on SEC.gov |
| May 20 | ALNY | Alnylam Pharmaceuticals,… | AGRANT | 671 | — | — | +73.7% | Open the original filing on SEC.gov |
| Apr 24 | TARS | Tarsus Pharmaceuticals,… | MEXER◆ | 1,383 | — | — | — | Open the original filing on SEC.gov |
| Apr 24 | TARS | Tarsus Pharmaceuticals,… | MEXER | 1,383 | — | — | — | Open the original filing on SEC.gov |